Lipid profiles and ovarian reserve status: a longitudinal study

Age-specific serum anti-Müllerian hormone levels: estimates from a large population-based sample

(2014) F. R. Tehrani et al.   CLIMACTERIC

Regulation of Endothelial Nitric Oxide Synthase and High-Density Lipoprotein Quality by Estradiol in Cardiovascular Pathology

(2014) Kyriakos E. Kypreos et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

A prospective, case–control study on the lipid profile and the cardiovascular risk of menopausal women on oestrogen plus progestogen therapy in a northern Italy province

(2013) Tito Silvio Patrelli et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study

(2013) Farhad Hosseinpanah et al.   CLINICAL ENDOCRINOLOGY

Sex and gender differences in control of blood pressure: Figure 1

(2013) Rodrigo Maranon et al.   CLINICAL SCIENCE

Membrane Estrogen Receptors: Their Role in Blood Pressure Regulation and Cardiovascular Disease

(2013) Roopashree Prabhushankar et al.   CURRENT HYPERTENSION REPORTS

Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized Trials

(2013) JoAnn E. Manson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Anti-Müllerian Hormone Is Not Associated with Cardiometabolic Risk Factors in Adolescent Females

(2013) Emma L. Anderson et al.   PLoS One

Sex Differences in Hypertension: Contribution of the Renin–Angiotensin System

(2012) Christine Maric-Bilkan et al.   Gender Medicine

Serum lipid levels in women with premature ovarian failure

(2012) Ibrahim Gulhan et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Premenopausal antimüllerian hormone concentration is associated with subsequent atherosclerosis

(2012) Susan E. Appt et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

HDL-C: Role as a risk modifier

(2011) Philip Barter   ATHEROSCLEROSIS SUPPLEMENTS

Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?

(2011) Piotr Skałba et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Cardiovascular Disease and Risk Factors in PCOS Women of Postmenopausal Age: A 21-Year Controlled Follow-Up Study

(2011) Johanna Schmidt et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Gender differences in the cardiovascular effects of sex hormones

(2010) Cristiana Vitale et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Is polycystic ovary syndrome an exception for reproductive aging?

(2010) F. Ramezani Tehrani et al.   HUMAN REPRODUCTION

The Polycystic Ovary Post-Rotterdam: A Common, Age-Dependent Finding in Ovulatory Women without Metabolic Significance

(2010) Erica B. Johnstone et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cardiovascular risk and events in polycystic ovary syndrome

(2009) E. Carmina   CLIMACTERIC

Testing ovarian reserve to predict age at menopause

(2009) C.B. Lambalk et al.   MATURITAS

Cardiovascular Disease Risk Factors in Polycystic Ovary Syndrome

(2008) Anuja Dokras   SEMINARS IN REPRODUCTIVE MEDICINE